Differentiation-inducing agents decrease cryptic prolactin receptors in cultured rat mammary tumor cells.
Normal proliferating and neoplastic mammary cells in culture have cryptic prolactin receptors. These cryptic sites represent 80-95% of the total receptors and can be unmasked by energy depletion. Since lactating mammary tissue and other prolactin targets do not contain cryptic receptors, we have suggested that these sites may be important in the growth response to prolactin. In this study, therefore, we determined the effects of dimethylsulfoxide (DMSO) and sodium butyrate, two inducers of differentiation in other cell systems, on primary cultures of 7,12-dimethylbenzanthracene-induced rat mammary tumors. These substances decreased cryptic receptor levels and inhibited growth. Sodium butyrate (5 mM) decreased receptor levels within 3 h; by 24 h, receptor levels averaged 11 +/- 3% of the controls (n = 13). Similarly, DMSO (1-5%) caused a dose-dependent decrease in receptor levels. With 4% DMSO, there was a progressive decrease in prolactin binding to a nadir of 22 +/- 6% of the controls (n = 8) at 12-24 h. Receptor levels returned to pretreatment values by 24 h after the removal of sodium butyrate or DMSO. In addition, sodium butyrate and DMSO increased the formation of the multicellular structures called 'domes' and the accumulation of lipid droplets. Since sodium butyrate and DMSO decreased cryptic sites, inhibited cell growth and evoked the expression of some morphologic features of differentiation, we conclude that the loss of cryptic prolactin receptors may be involved in the acquisition of a differentiated phenotype in mammary cells.
D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D002454:Cell Differentiation / Q000187:drug effects*; D002478:Cells, Cultured; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000473:pathology*; D051381:Rats; D011919:Rats, Inbred Strains; D011956:Receptors, Cell Surface / Q000187:drug effects*; D011981:Receptors, Prolactin; D012176:Retinoids / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D002087:Butyrates; D005227:Fatty Acids; D011956:Receptors, Cell Surface; D011981:Receptors, Prolactin; D012176:Retinoids; D020148:Butyric Acid; D013755:Tetradecanoylphorbol Acetate; D004121:Dimethyl Sulfoxide